Meike Brinker

956 citations

39 papers · 333 indexed · 1 hit paper · h-index 12

Impact in

Endocrinology, Diabetes and Metabolism top 5%
- Hormonal Regulation and Hypertension
- Diabetes Treatment and Management
Nephrology top 10%
- Chronic Kidney Disease and Diabetes

Papers in ⓘ

Endocrinology, Diabetes and Metabolism 32
- Hormonal Regulation and Hypertension 23
- Diabetes Treatment and Management 15
Cardiology and Cardiovascular Medicine 20
- Blood Pressure and Hypertension Studies 11
- Heart Failure Treatment and Management 9
- Cardiovascular Function and Risk Factors 4

Co-authors: Peter Rossing (19 shared papers)Bertram Pitt (13 shared papers)Stefan D. Anker (16 shared papers)Amer Joseph (8 shared papers)George L. Bakris (13 shared papers)Gerasimos Filippatos (14 shared papers)Luís M. Ruilope (16 shared papers)Hiddo J.L. Heerspink (10 shared papers)
Journals: Journal of the American Society of Nephrology (7 papers)European Journal of Heart Failure (3 papers)Diabetes Obesity and Metabolism (3 papers)Kidney International (3 papers)Journal of the American College of Cardiology (2 papers)
Partner nations: Germany United States Denmark

In The Last Decade

Meike Brinker

29 papers receiving 325 citations

Hit Papers

align trajectories log scale

Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes 2025 · 44 citations

Peers

Countries citing papers authored by Meike Brinker

Since Specialization

Citations

This map shows the geographic impact of Meike Brinker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meike Brinker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meike Brinker more than expected).

Fields of papers citing papers by Meike Brinker

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Meike Brinker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meike Brinker. The network helps show where Meike Brinker may publish in the future.

Co-authors

The 25 scholars most cited alongside Meike Brinker, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Meike Brinker Line = papers co-authored together Meike Brinker links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 39 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	A prespecified exploratory analysis from FIDELITY examined finerenone use and kidney outcomes in patients with chronic kidney disease and type 2 diabetes Kidney International ·George L. Bakris, Luís M. Ruilope, Stefan D. Anker, Gerasimos Filippatos, Bertram Pitt, Peter Rossing, Linda P. Fried, Prabir Roy‐Chaudhury, Pantelis Sarafidis, Christiane Ahlers, Meike Brinker, Amer Joseph, Robert Lawatscheck, Rajiv Agarwal	2022	46
2	Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes New England Journal of Medicine ·Rajiv Agarwal, Jennifer B. Green, Hiddo J.L. Heerspink, Johannes F.E. Mann, Janet B. McGill, Amy K. Mottl, Julio Rosenstock, Peter Rossing, Muthiah Vaduganathan, Meike Brinker, Robert Edfors, Na Li, Markus F. Scheerer, Charlie Scott, Masaomi Nangaku Hit paper breakdown →	2025	44
3	Effects of the Nonsteroidal MRA Finerenone With and Without Concomitant SGLT2 Inhibitor Use in Heart Failure Circulation ·Muthiah Vaduganathan, Brian Claggett, Ian J. Kulac, Zi Michael Miao, Akshay S. Desai, Pardeep S. Jhund, Alasdair Henderson, Meike Brinker, James Lay‐Flurrie, Prabhakar Viswanathan, Markus F. Scheerer, Andrea Lage, Carolyn S.P. Lam, Michele Senni, Sanjiv J. Shah, Adriaan A. Voors, Faı̈ez Zannad, Bertram Pitt, John J.V. McMurray, Scott D. Solomon	2024	25
4	Outcomes with Finerenone in Participants with Stage 4 CKD and Type 2 Diabetes Clinical Journal of the American Society of Nephrology ·Pantelis Sarafidis, Rajiv Agarwal, Bertram Pitt, Christoph Wanner, Gerasimos Filippatos, John Boletis, Katherine R. Tuttle, Luís M. Ruilope, Peter Rossing, Robert Toto, Stefan D. Anker, Zhihong Liu, Amer Joseph, Christiane Ahlers, Meike Brinker, Robert Lawatscheck, George L. Bakris, (unknown)	2023	25
5	Finerenone and effects on mortality in chronic kidney disease and type 2 diabetes: a FIDELITY analysis European Heart Journal - Cardiovascular Pharmacotherapy ·Gerasimos Filippatos, Stefan D. Anker, Phyllis August, Andrew J.S. Coats, James L. Januzzi, Boris Mankovsky, Peter Rossing, Luís M. Ruilope, Bertram Pitt, Pantelis Sarafidis, John R. Teerlink, Chris J. Kapelios, Martin Gebel, Meike Brinker, Amer Joseph, Andrea Lage, George L. Bakris, Rajiv Agarwal	2023	24
6	Finerenone Dose–Exposure–Serum Potassium Response Analysis of FIDELIO-DKD Phase III: The Role of Dosing, Titration, and Inclusion Criteria Clinical Pharmacokinetics ·Sebastiaan C. Goulooze, Nelleke Snelder, Andreas Seelmann, Andrea Horvat-Broecker, Meike Brinker, Amer Joseph, Dirk Garmann, Jörg Lippert, Thomas Eißing	2021	23
7	Finerenone and Kidney Outcomes in Patients With Heart Failure Journal of the American College of Cardiology ·Finnian R. Mc Causland, Muthiah Vaduganathan, Brian Claggett, Ian J. Kulac, Akshay S. Desai, Pardeep S. Jhund, Alasdair Henderson, Meike Brinker, Robert Perkins, Markus F. Scheerer, Patrick Schloemer, Carolyn S.P. Lam, Michele Senni, Sanjiv J. Shah, Adriaan A. Voors, Faı̈ez Zannad, Bertram Pitt, John J.V. McMurray, Scott D. Solomon	2024	21
8	Development and Validation of a New Hierarchical Composite End Point for Clinical Trials of Kidney Disease Progression Journal of the American Society of Nephrology ·Hiddo J.L. Heerspink, Niels Jongs, Patrick Schloemer, Dustin J. Little, Meike Brinker, Christoph Tasto, Martin Karpefors, David C. Wheeler, George L. Bakris, Vlado Perkovic, Richard Nkulikiyinka, Jérôme Rossert, Samvel B. Gasparyan	2023	15
9	Effect of finerenone on the occurrence of vision‐threatening complications in patients with non‐proliferative diabetic retinopathy: Pooled analysis of two studies using routine ophthalmological examinations from clinical trial participants ( ReFineDR / DeFineDR ) Diabetes Obesity and Metabolism ·Peter Rossing, Justus G. Garweg, Stefan D. Anker, Takeshi Osonoi, Bertram Pitt, Sylvia E. Rosas, Luis Miguel Ruilope, Dalong Zhu, Meike Brinker, David Finis, Sergio Leal, Thomas Schmelter, George L. Bakris	2022	14
10	Dose–Exposure–Response Analysis of the Nonsteroidal Mineralocorticoid Receptor Antagonist Finerenone on UACR and eGFR: An Analysis from FIDELIO-DKD Clinical Pharmacokinetics ·Sebastiaan C. Goulooze, Hiddo J.L. Heerspink, Martijn van Noort, Nelleke Snelder, Meike Brinker, Jörg Lippert, Thomas Eißing	2022	12
11	Validity and Utility of a Hierarchical Composite End Point for Clinical Trials of Kidney Disease Progression: A Review Journal of the American Society of Nephrology ·Dustin J. Little, Samvel B. Gasparyan, Patrick Schloemer, Niels Jongs, Meike Brinker, Martin Karpefors, Christoph Tasto, Nicole Rethemeier, Lars Frison, Richard Nkulikiyinka, Jérôme Rossert, Hiddo J.L. Heerspink	2023	11
12	Association of Finerenone Use With Reduction in Treatment-Emergent Pneumonia and COVID-19 Adverse Events Among Patients With Type 2 Diabetes and Chronic Kidney Disease JAMA Network Open ·Bertram Pitt, Rajiv Agarwal, Stefan D. Anker, Luís M. Ruilope, Peter Rossing, Christiane Ahlers, Meike Brinker, Amer Joseph, Marc Lambelet, Robert Lawatscheck, Gerasimos Filippatos, (unknown)	2022	11
13	Finerenone cardiovascular and kidney outcomes by age and sex: FIDELITY post hoc analysis of two phase 3, multicentre, double-blind trials BMJ Open ·Shweta Bansal, Maria Eugênia Fernandes Canziani, Rita Birne, Stefan D. Anker, George L. Bakris, Gerasimos Filippatos, Peter Rossing, Luís M. Ruilope, Alfredo E. Farjat, Peter Kolkhof, Andrea Lage, Meike Brinker, Bertram Pitt	2024	10
14	Effects of finerenone in people with chronic kidney disease and type 2 diabetes are independent of HbA1c at baseline, HbA1c variability, diabetes duration and insulin use at baseline Diabetes Obesity and Metabolism ·Janet B. McGill, Rajiv Agarwal, Stefan D. Anker, George L. Bakris, Gerasimos Filippatos, Bertram Pitt, Luís M. Ruilope, Andreas L. Birkenfeld, Maria Luiza Caramori, Meike Brinker, Amer Joseph, Andrea Lage, Robert Lawatscheck, Charlie Scott, Peter Rossing, (unknown)	2023	9
15	Pharmacokinetics and pharmacodynamics of finerenone in patients with chronic kidney disease and type 2 diabetes: Insights based on FIGARO‐DKD and FIDELIO‐DKD Diabetes Obesity and Metabolism ·Thomas Eißing, Sebastiaan C. Goulooze, Paul van den Berg, Martijn van Noort, Martijn Ruppert, Nelleke Snelder, Dirk Garmann, Jörg Lippert, Roland Heinig, Meike Brinker, Hiddo J.L. Heerspink	2023	8
16	Efficacy and safety of finerenone in patients with an acute change in estimated glomerular filtration rate in the prespecified FIDELITY pool analysis Kidney International ·Sankar D. Navaneethan, Stefan D. Anker, Gerasimos Filippatos, Bertram Pitt, Peter Rossing, Luís M. Ruilope, Phyllis August, Meike Brinker, Andrea Lage, Luke Roberts, Charlie Scott, Pantelis Sarafidis	2025	7
17	Clinical characteristics and disease outcomes in non-diabetic chronic kidney disease: retrospective analysis of a US healthcare claims database Journal of Nephrology ·Christoph Wanner, Johannes Schuchhardt, Chris Bauer, Stefanie Lindemann, Meike Brinker, Sheldon X. Kong, Frank Kleinjung, Andrea Horvat-Broecker, Tatsiana Vaitsiakhovich	2022	7
18	Risk of chronic kidney disease in patients with acute kidney injury following a major surgery: a US claims database analysis Clinical Kidney Journal ·Christoph Ohlmeier, Johannes Schuchhardt, Chris Bauer, Meike Brinker, Sheldon X. Kong, Charlie Scott, Tatsiana Vaitsiakhovich	2023	6
19	Finerenone Across the Spectrum of Kidney Risk in Heart Failure JACC Heart Failure ·John W. Ostrominski, Finnian R. Mc Causland, Brian Claggett, Akshay S. Desai, Pardeep S. Jhund, (unknown), Michele Senni, Sanjiv J. Shah, Adriaan A. Voors, Faı̈ez Zannad, Bertram Pitt, Patrick Schloemer, Meike Brinker, Markus F. Scheerer, John J.V. McMurray, Scott D Solomon, Muthiah Vaduganathan	2025	3
20	Finerenone and Left Ventricular Hypertrophy in Chronic Kidney Disease and Type 2 Diabetes ESC Heart Failure ·Gerasimos Filippatos, Stefan D. Anker, George L. Bakris, Peter Rossing, Luís M. Ruilope, Andrew J.S. Coats, Stephan von Haehling, Piotr Ponikowski, Giuseppe Rosano, Meike Brinker, Alfredo E. Farjat, Luke Roberts, Bertram Pitt, (unknown)	2024	2

About Meike Brinker

Meike Brinker is a scholar working on Endocrinology, Diabetes and Metabolism, Cardiology and Cardiovascular Medicine, Nephrology, Statistics and Probability and Pulmonary and Respiratory Medicine, having authored 39 papers that have together received 333 indexed citations. Recurring topics across this work include Hormonal Regulation and Hypertension (23 papers), Diabetes Treatment and Management (15 papers), Blood Pressure and Hypertension Studies (11 papers), Heart Failure Treatment and Management (9 papers), Electrolyte and hormonal disorders (5 papers), Cardiovascular Function and Risk Factors (4 papers), Advanced Causal Inference Techniques (3 papers) and Statistical Methods in Clinical Trials (3 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (213 citations), Nephrology (50 citations), Cardiology and Cardiovascular Medicine (125 citations), Pulmonary and Respiratory Medicine (87 citations) and Transplantation (4 citations). Meike Brinker has collaborated with scholars based in Germany, United States and Denmark. Frequent co-authors include Peter Rossing, Bertram Pitt, Stefan D. Anker, Amer Joseph, George L. Bakris, Gerasimos Filippatos, Luís M. Ruilope, Hiddo J.L. Heerspink, Rajiv Agarwal and Pantelis Sarafidis. Their work appears in journals such as Journal of the American Society of Nephrology, European Journal of Heart Failure, Diabetes Obesity and Metabolism, Kidney International and Journal of the American College of Cardiology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact